For the quarter ended December 2024, Teladoc (TDOC) reported revenue of $640.49 million, down 3% over the same period last year. EPS came in at -$0.28, compared to -$0.17 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $639.5 million, representing a surprise of +0.16%. The company delivered an EPS surprise of -33.33%, with the consensus EPS estimate being -$0.21.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and ho ...

Teladoc (TDOC) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to loss of $0.17 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -33.33%. A quarter ago, it was expected that this telehealth services provider would post a loss of $0.29 per share when it actually produced a loss of $0.19, delivering a surprise of 34.48%.Over the last four quarters, the compan ...

Teladoc Health reported weak fourth-quarter results as challenges in its BetterHelp segment weighed down gains elsewhere in the business.Teladoc Health (TDOC -1.70%), a leader in telehealth services, released its fourth-quarter earnings on Feb. 26. The company reported revenue of $640.5 million, just above the $639 million that analysts had expected, but 3% lower than the same quarter last year. Its net loss per share was $0.28, worse than the loss of $0.26 per share that analysts had anticipated. MetricQ4 ...

Core Viewpoint - Teladoc Health reported a wider loss than expected and provided disappointing guidance for the upcoming quarter, leading to a decline in its stock price [1][2]. Financial Performance - Revenue decreased by 3% in Q4 to $640.5 million compared to $660.5 million in the same period last year [1][6]. - Net loss widened to $48.4 million, or 28 cents per share, from a loss of $28.9 million, or 17 cents per share, a year ago [1]. - Adjusted earnings fell by 35% to $74.8 million in Q4, with the Integrated Care segment down 5% to $53.2 million and BetterHelp's adjusted earnings dropping 63% to $21.7 million [3]. Future Guidance - For Q1, Teladoc expects revenue between $608 million and $629 million, below analysts' expectations of $632.9 million [4]. - Adjusted earnings for the first quarter are projected to be between $47 million and $59 million [4]. Strategic Moves - Teladoc announced the acquisition of preventative care company Catapult Health for $65 million, which is expected to contribute to future growth [5].

4Q-24 Quarterly Results Cautionary Note 2 • This presentation contains, and the officers of Teladoc Health, Inc. (the "Company" or "Teladoc Health") may make, "forward-looking" statements that are based on management's beliefs and assumptions and on information currently available to management. These forward-looking statements include, without limitation, information concerning possible or assumed future results of operations, including descriptions of the Company's business plan and strategies. These stat ...

Exhibit 99.1 Teladoc Health Reports Full Year and Fourth Quarter 2024 Results PURCHASE, NY, February 26, 2025—Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today reported financial results for the full year ended December 31, 2024 ("Full Year 2024") and three months ended December 31, 2024 ("Fourth Quarter 2024"). Unless otherwise noted, percentage and other changes are relative to the full year ended December 31, 2023 ("Full Year 2023") and three months ended December 3 ...

Core Insights - Teladoc Health reported a net loss of $1,001.2 million for the full year 2024, significantly higher than the $220.4 million loss in 2023, primarily due to a non-cash goodwill impairment charge of $790 million related to the BetterHelp segment [7][13][12] - The company experienced a 1% decline in total revenue for the full year 2024, totaling $2,569.6 million compared to $2,602.4 million in 2023 [7][11] - Integrated Care segment revenue increased by 4% year-over-year, while BetterHelp segment revenue decreased by 8% for the full year 2024 [12][15] Financial Performance - Fourth Quarter 2024 revenue decreased by 3% to $640.5 million from $660.5 million in the same quarter of 2023 [6][7] - The net loss for Fourth Quarter 2024 was $48.4 million, compared to a loss of $28.9 million in Fourth Quarter 2023 [8][7] - Adjusted EBITDA for Fourth Quarter 2024 was $74.8 million, down 35% from $114.4 million in Fourth Quarter 2023 [9][15] Revenue Breakdown - Access fees revenue for Fourth Quarter 2024 decreased by 5% to $543.1 million, while other revenue grew by 12% to $97.4 million [6][11] - U.S. revenue decreased by 5% to $535.4 million, while international revenue grew by 10% to $105.1 million in Fourth Quarter 2024 [6][11] - For the full year 2024, U.S. revenue decreased by 3% to $2,160.0 million, while international revenue increased by 12% to $409.6 million [11][12] Cost and Cash Flow - Operating cash flow for the full year 2024 was $293.7 million, down from $350.0 million in 2023 [7][17] - Free cash flow for the full year 2024 was $169.6 million, compared to $193.7 million in 2023 [7][18] - Capital expenditures for the full year 2024 were $124.1 million, down from $156.3 million in 2023 [18] Future Outlook - For the full year 2025, Teladoc expects revenue in the range of $2,468 million to $2,576 million and adjusted EBITDA between $278 million and $319 million [19][20] - The company anticipates a net loss per share for 2025 in the range of ($1.10) to ($0.50) [20][21] - The guidance includes contributions from the acquisition of Catapult Health, expected to close at the end of February 2025 [19][20]

Core Viewpoint - Edelson Lechtzin LLP is investigating potential violations of federal securities laws involving Teladoc Health Inc. due to allegations of misleading business information provided to investors [1] Company Overview - Teladoc Health is a telemedicine and virtual healthcare provider [2] Allegations of Wrongdoing - Blue Orca Capital has issued a report claiming a short position in Teladoc, alleging that the company provides mental health therapy through an AI platform rather than licensed therapists. This practice incentivizes therapists to generate longer, generic messages, which can be easily produced by AI [3] - Therapists are reportedly compensated based on the quantity of words in their responses, leading to potential quality issues in patient communication [3] - Blue Orca's claims are supported by field research, including patient interviews where therapists admitted to using AI in communications [3] Accounting Practices - Blue Orca alleges that Teladoc is using questionable accounting techniques to inflate profitability and cash flows by shifting R&D expenses from the income statement to investing cash flows. This manipulation reportedly inflated EBITDA by up to 32% and operating cash flows by 127% for FY 2023 [4] Profitability Concerns - Blue Orca believes that Teladoc is less profitable and generates significantly less cash than investors are led to believe. The use of AI in mental health treatment is expected to lead to a deterioration of that business and a decline in stock price [5]

Core Insights - Analysts project that Teladoc (TDOC) will report a quarterly loss of $0.21 per share, reflecting a year-over-year decline of 23.5% [1] - Revenue is expected to reach $639.5 million, down 3.2% from the same quarter last year [1] - There have been no revisions in the consensus EPS estimate over the last 30 days, indicating analysts' stable outlook [1] Revenue Projections - The consensus estimate for 'Revenues by Segment- BetterHelp' is $246.59 million, indicating a decline of 10.7% year-over-year [4] - 'Revenues by Segment- Teladoc Health Integrated Care' is projected at $389.73 million, suggesting a slight increase of 1.4% year-over-year [4] - 'Revenues by Segment- BetterHelp- Therapy Services' is expected to be $240.36 million, down 11.4% from the prior year [5] - 'Revenues by Segment- BetterHelp- Other Wellness Services' is anticipated to reach $6.36 million, reflecting a significant increase of 29.9% year-over-year [5] Revenue by Type - Analysts expect 'Revenue by Type- Access fees' to be $543.58 million, indicating a decrease of 5.3% from the previous year [6] - The consensus for 'Revenue by Type- Other' stands at $83.99 million, showing a year-over-year decline of 3% [6] Membership and EBITDA Estimates - The projected number of 'U.S. Integrated Care Members' is 94.17 million, an increase from 89.6 million reported in the same quarter last year [6] - 'Adjusted EBITDA- BetterHelp' is expected to be $29.00 million, down from $58.47 million a year ago [7] - 'Adjusted EBITDA- Teladoc Health Integrated Care' is projected at $51.62 million, compared to $55.97 million in the prior year [7] Stock Performance - Teladoc shares have increased by 25.2% over the past month, outperforming the Zacks S&P 500 composite, which rose by 2.2% [7] - The company holds a Zacks Rank 3 (Hold), indicating it is expected to closely follow overall market performance in the near term [7]

Group 1 - Block & Leviton is investigating Teladoc Health, Inc. for potential securities law violations following a report by Blue Orca Capital [1][2] - Teladoc Health's shares fell over 12% on February 20 due to allegations of misleading investors regarding its BetterHelp platform and financial reporting [2] - The allegations include the use of AI-generated responses instead of licensed therapists and accusations of inflating profitability by shifting R&D expenses [2] Group 2 - Investors who have lost money in Teladoc Health, Inc. may be eligible to recover losses and are encouraged to contact Block & Leviton [3][4] - Block & Leviton is recognized as a leading securities class action firm, having recovered billions for defrauded investors [7] - Whistleblowers with non-public information about Teladoc Health, Inc. may assist in the investigation and could receive rewards from the SEC [6]